Literature DB >> 33854760

Lung adenocarcinoma diagnosed incidentally after renal biopsy for suspected right renal cancer.

Sat Prasad Nepal1, Takeshi Shichijo1, Yoshio Ogawa1, Takehiko Nakasato1, Yoshihiro Nakagami1, Jun Morita1, Kazuhiko Oshinomi1, Yoshiko Maeda1, Tsutomu Unoki1, Tatsuki Inoue1, Ryosuke Kato1, Satoshi Amano1, Moyuru Mizunuma1.   

Abstract

We present a case of lung adenocarcinoma metastasizing to the right clear cell renal cell carcinoma diagnosed by computed tomography (CT)-guided renal biopsy and immunohistochemistry. A 72-year-old male patient had right lower abdominal pain for 3 days, followed by right loin pain for 10 days. On CT scan, renal cell cancer was suspected with multiple metastases. Renal cell cancer with metastatic lung adenocarcinoma was diagnosed on CT-guided renal biopsy with positive immunohistochemical markers. The patient, unfortunately, expired after few days of diagnosis. Tumor-to-tumor metastasis is an unusual disease, and its tumors are aggressive. A definite diagnosis of tumor-to-tumor metastasis is a clinical challenge. Immunohistochemistry helped us in the diagnosis without the primary lesion biopsy. Published by Oxford University Press and JSCR Publishing Ltd.
© The Author(s) 2021.

Entities:  

Year:  2021        PMID: 33854760      PMCID: PMC8024040          DOI: 10.1093/jscr/rjab092

Source DB:  PubMed          Journal:  J Surg Case Rep        ISSN: 2042-8812


INTRODUCTION

Tumor-to-tumor metastasis is an incredibly unique phenomenon, identified using the following criteria: (1) presence of two or more distinct tumors; (2) the tumor should not be a lymph node involved in lymphoreticular tumors; (3) extravascular metastasis and (4) not a collision tumor (two distinct tumors connected by a transitional zone) [1, 2]. In these cases, renal cancer is the most common recipient, whereas lung cancer is the most common donor [2, 3]. Majority of cases are diagnosed in autopsy [2].

CASE REPORT

A 72-year-old patient presented with continuous pain in the right lower abdomen and right lower ribs (around the 11th rib) for 3 days, followed by right loin and back pain for 10 days. The patient took painkillers with sleeping pills for pain relief, but this was ineffective, prompting consult to our hospital. He has a history of hypertension and gout, managed with amlodipine, febxostat, ethyl eicosapentaenoic acid, magnesium oxide and brotizolam. He also has 50 pack-year smoking history. The patient has undergone an appendectomy and also had a right putamen hemorrhage 4 years ago. His father had lung cancer, whereas his mother had laryngeal cancer. On arrival, his C-reactive protein was elevated (2.84), and urine cytology was Class II. Other blood examinations were within normal limits. On computed tomography (CT) scan, there was a 38-mm right renal mass, giving an impression of renal cancer, right hilar lung tumor, and bone, lungs, brain, and, liver metastases, with right pleural effusion (Fig. 1). We wanted to check if the renal mass was a primary renal cell cancer or metastatic; a CT-guided renal biopsy was then planned.
Figure 1

Computed tomography scan showing (A) a 38-mm right renal mass (suspected renal cancer), (B) right hilar lung cancer, with metastasis in the (C and D) bone, (E) lungs, (F) brain and (G) liver.

Computed tomography scan showing (A) a 38-mm right renal mass (suspected renal cancer), (B) right hilar lung cancer, with metastasis in the (C and D) bone, (E) lungs, (F) brain and (G) liver. We found a clear cell renal cell cancer with a metastatic lung adenocarcinoma on CT-guided renal biopsy (Fig. 2). We were able to diagnose lung cancer from renal biopsy by immunohistochemical staining (Thyroid transcription factor 1 [TTF-1] and Napsin positive) without the primary lung tumor biopsy. The tumor was also positive for the following immunohistochemical markers: vimentin, cluster of differentiation 10 (CD10), heat shock protein 70, Glypcian-3, hepatocyte-specific antigen and paired-box gene 8.
Figure 2

Histology showed a proliferation of large nucleated atypical cells and eosinophilic cytoplasm. Some multinucleated cells with distinct nucleolus are scattered.

Histology showed a proliferation of large nucleated atypical cells and eosinophilic cytoplasm. Some multinucleated cells with distinct nucleolus are scattered. A bone scan index, with a value of 0.62, revealed nine hot spot lesions on the thoracic and lumbar vertebra and ilium. After 3 days of admission, the patient’s oxygen saturation started dropping. White blood cell count, lactate dehydrogenase, alkaline phosphatase, aspartate transaminase and D-dimers were all elevated. The patient unfortunately expired 10 days later due to pneumonia and sepsis.

DISCUSSION

What makes our case unique is that lung cancer was first discovered incidentally through chest CT scan and immunohistology of renal biopsy, before the onset of any classic symptoms of lung adenocarcinoma (continuous cough, bloody sputum, shortness of breath and weight loss). Moreover, clinical diagnosis of lung tumor to kidney tumor metastasis is extremely uncommon [1, 2, 4–8] (Table 1).
Table 1

Relevant literature on lung cancer metastatic to renal cell carcinoma

SNAuthor (Year)Age/SexLung cancer histologyRCC location
1Schmorl (1928)a
2Walther (1948)a47 MLt
3Rabson (1954)a58 MLt
4Rabson (1954)a65 MMucoid adenocarcinomaLt
56Boyd (1955) (2 cases)a
7Dobbing (1958)a71 MLt
8Wheelock (1962)a
9Moerterl (1966)a
10Campbell (1968)a74 MBronchogenic caRt
11Ottoson L (1968)b74Adenocarcinoma
12Ottoson L (1968)b77Oat cell bronchial ca
13Maloney (1968)b59 MUndifferentiated lung caRt
14Sharma (1969)b59 MUndifferentiated small cell caRt
15Ichijima (1980)b41 FModerately differentiated Lung adenocarcinomaLt
16Shuangshoti (1983)b79 FPoorly differentiated adenocarcinomaLt
17Sella (1987)b56 FPoorly differentiated adenocarcinomaRt
18Hibi (1991)62 MOat cell carcinoma of lungLt
19Granville (2005)b65 FModerately differentiated adenocarcinomaLt
20Sawada (2009)b97 FPoorly differentiated Lung adenocarcinomaLt
21Duprez (2009)60 MNeuroendocrine lung cancerLt
22Aggarwal N (2012)57 MNon-small cell Lung caLt
23Matsukuma S (2013)88 MLung adenocarcinomaLt
24Matsukuma S (2013)69 MLung adenocarcinomaRt
25Matsukuma S (2013)72 MLung adenocarcinomaRt
26Matsukuma S (2013)48 MLung adenocarcinomaLt
27Matsukuma S (2013)82 MSmall cell lung carcinomaLt
28Huang H (2016)Lung adenocarcinoma
29Our case (2021)72 MLung adenocarcinomaRt

aReview of Campbell et al. [1].

bReview of Sawada et al. [4].

Empty spaces means unknown; M: male, F: female; RCC: renal cell carcinoma; Lt: left, Rt: right.

Relevant literature on lung cancer metastatic to renal cell carcinoma aReview of Campbell et al. [1]. bReview of Sawada et al. [4]. Empty spaces means unknown; M: male, F: female; RCC: renal cell carcinoma; Lt: left, Rt: right. In tumor-to-tumor metastasis, lung cancer is the most common donor, whereas kidney cancer is the most common recipient [3]. The pathogenesis for this is still being studied. The ‘seed and soil’ theory speculates that this is due to the recipient’s hypervascularity, making it easier for circulating tumor cells to arrive from the donor and because the recipient cells form a suitable environment for donor cells [2]. Kidney’s vascularity and glycogen and lipid richness cause it to be a favorable recipient of metastatic tumor [1, 9]. Immunohistology aided us in identifying markers of lung adenocarcinoma metastasis (TTF-1 and Napsin) without the primary lung tumor biopsy. Tumor-to-tumor metastasis is aggressive in nature and carries a poor prognosis [2]. Our patient presented with multiple lung, brain and liver metastases, suggesting its aggressive nature. We could not start anti-cancer treatment for the patient as he had reduced oxygen saturation, after which he regrettably expired. In conclusion, we present a rare clinical case of lung to kidney, tumor-to-tumor metastasis diagnosed by CT-guided renal biopsy and immunohistochemistry. This condition is hard to diagnose clinically and has a poor prognosis.

CONSENT FOR THE ARTICLE

Written informed consent was obtained from the patient’s next of kin for publication of this case report and any accompanying images.

CONFLICT OF INTEREST STATEMENT

None declared.

FUNDING

None.
  9 in total

Review 1.  [A case of metastasis of lung cancer to renal cell carcinoma].

Authors:  H Hibi; K Itoh; K Ono; Y Yamada; T Shimoji
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1991-03

2.  [Tumor-to-tumor metastasis: report of three cases].

Authors:  Raphaëlle Duprez; Sylvie Thimon; Rémy Kerdraon; Carole Bonneau; David Metois; Patrick Michenet
Journal:  Ann Pathol       Date:  2009-12       Impact factor: 0.407

3.  Metastases of cancer to cancer.

Authors:  L V Campbell; E Gilbert; C R Chamberlain; A L Watne
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

4.  Tumor-to-tumor metastasis: case report of a pulmonary adenocarcinoma metastatic to a clear cell renal cell carcinoma.

Authors:  Nidhi Aggarwal; Rajnikant M Amin; Daniel Chung; Anil V Parwani
Journal:  Pathol Res Pract       Date:  2011-11-17       Impact factor: 3.250

5.  Secondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases.

Authors:  He Huang; Pheroze Tamboli; Jose A Karam; Raghu Vikram; Miao Zhang
Journal:  Hum Pathol       Date:  2016-02-01       Impact factor: 3.466

6.  Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.

Authors:  Susumu Matsukuma; Takako Kono; Hiroaki Takeo; Yusuke Hamakawa; Kimiya Sato
Journal:  Virchows Arch       Date:  2013-08-03       Impact factor: 4.064

7.  Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney.

Authors:  Reva Ricketts; Pheroze Tamboli; Bogdan Czerniak; Charles C Guo
Journal:  Arch Pathol Lab Med       Date:  2008-06       Impact factor: 5.534

8.  Renal cell cancer: best recipient of tumor-to-tumor metastasis.

Authors:  A Sella; J Y Ro
Journal:  Urology       Date:  1987-07       Impact factor: 2.649

Review 9.  Tumor-to-tumor metastasis: report of an autopsy case of lung adenocarcinoma metastasizing to renal cell carcinoma.

Authors:  Takeshi Sawada; Hiroyuki Takahashi; Kenkei Hasatani; Isao Yoshida; Osamu Oyama; Ryo Inoue; Kenji Miwa; Masa-aki Kawashiri; Katsushi Misawa; Masanori Kyoi; Susumu Miyamoto
Journal:  Intern Med       Date:  2009-09-01       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.